Search Results - Jo-Anne Vergilio

Refine Results
  1. 1
    Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia

    Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia by Kalindi Parmar, Peter Mauch, Jo‐Anne Vergilio, Robert Sackstein, Julian D. Down

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Recent advances in the understanding of Langerhans cell histiocytosis

    Recent advances in the understanding of Langerhans cell histiocytosis by Gayane Badalian‐Very, Jo‐Anne Vergilio, Barbara Degar, Carlos Rodríguez‐Galindo, Barrett J. Rollins

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation

    Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation by D J Falcone, Timothy A. McCaffrey, Adriana Haimovitz–Friedman, Jo‐Anne Vergilio, Andrew Nicholson

    Published 1993
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Philadelphia Chromosome–Positive Acute Myeloid Leukemia

    Philadelphia Chromosome–Positive Acute Myeloid Leukemia by Chad P. Soupir, Jo-Anne Vergilio, Paola Dal Cin, Alona Muzikansky, Hagop M. Kantarjian, Dan Jones, Robert P. Hasserjian

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13

    MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13 by Vijay G. Sankaran, Tobias Menne, Danilo Šćepanović, Jo-Anne Vergilio, Peng Ji, Jin‐Kuk Kim, Prathapan Thiru, Stuart H. Orkin, Eric S. Lander, Harvey F. Lodish

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting

    Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting by Maria Arroz, Neil Came, Pei Lin, Weina Chen, Constance M. Yuan, Anand S. Lagoo, Mariela Monreal, Ruth de Tute, Jo‐Anne Vergilio, Andy C. Rawstron, Bruno Paiva

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia

    Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia by Vijay G. Sankaran, Roxanne Ghazvinian, Ron Do, Prathapan Thiru, Jo‐Anne Vergilio, Alan H. Beggs, Colin A. Sieff, Stuart H. Orkin, David G. Nathan, Eric S. Lander, Hanna T. Gazda

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Utility of FDG-PET scanning in lymphoma by WHO classification

    Utility of FDG-PET scanning in lymphoma by WHO classification by Rebecca Elstrom, Liang Guan, Gary Baker, Khozaim Nakhoda, Jo‐Anne Vergilio, Hongming Zhuang, Stephanie Pitsilos, Adam Bagg, Lisa Downs, Amit K. Mehrotra, Scott Y. H. Kim, Abass Alavi, Stephen J. Schuster

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association

    SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association by Douglas I. Lin, Justin Allen, Jonathan L. Hecht, Jonathan Keith Killian, Nhu Ngo, Claire Edgerly, Eric A. Severson, Siraj M. Ali, Rachel Erlich, Shakti Ramkissoon, Jo‐Anne Vergilio, Jeffrey S. Ross, Julia A. Elvin

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials

    Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May... by James Suh, Adrienne Johnson, Lee A. Albacker, Kai Wang, Juliann Chmielecki, Garrett M. Frampton, Laurie M. Gay, Julia A. Elvin, Jo‐Anne Vergilio, Siraj M. Ali, Vincent A. Miller, Philip J. Stephens, Jeffrey S. Ross

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials

    Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials by Natalie Galanina, Rafael Bejar, Michael Y. Choi, Aaron M. Goodman, Matthew J. Wieduwilt, Carolyn Mulroney, Lisa Kim, Huwate Yeerna, Pablo Tamayo, Jo‐Anne Vergilio, Tariq I. Mughal, Vincent A. Miller, Catriona Jamieson, Razelle Kurzrock

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Nonamplification <i>ERBB2</i> genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti‐HER2 targeted therapies

    Nonamplification <i>ERBB2</i> genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti‐HER2 targeted therapies by Jeffrey S. Ross, Laurie M. Gay, Kai Wang, Siraj M. Ali, Saranya Chumsri, Julia A. Elvin, Ron Bose, Jo‐Anne Vergilio, James Suh, Roman Yelensky, Doron Lipson, Juliann Chmielecki, Stanley E. Waintraub, Brian Leyland‐Jones, Vincent A. Miller, Philip J. Stephens

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in <i>ERBB2</i> and <i>ERBB3</i>

    Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in <i>ERBB2</i> and <i>ERBB3</i> by Jeffrey S. Ross, Marwan Fakih, Siraj M. Ali, Julia A. Elvin, Alexa B. Schrock, James Suh, Jo‐Anne Vergilio, Shakti Ramkissoon, Eric A. Severson, Sugganth Daniel, David Fabrizio, Garrett M. Frampton, James Sun, Vincent A. Miller, Philip J. Stephens, Laurie M. Gay

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    The distribution of <i> <scp>BRAF</scp> </i> gene fusions in solid tumors and response to targeted therapy

    The distribution of <i> <scp>BRAF</scp> </i> gene fusions in solid tumors and response to targeted therapy by Jeffrey S. Ross, Kai Wang, Juliann Chmielecki, Laurie M. Gay, Adrienne Johnson, Jacob Chudnovsky, Roman Yelensky, Doron Lipson, Siraj M. Ali, Julia A. Elvin, Jo‐Anne Vergilio, Steven Roels, Vincent A. Miller, Brooke N. Nakamura, Adam Gray, Michael K.K. Wong, Philip J. Stephens

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Recurrent BRAF mutations in Langerhans cell histiocytosis

    Recurrent BRAF mutations in Langerhans cell histiocytosis by Gayane Badalian‐Very, Jo‐Anne Vergilio, Barbara Degar, Laura E. MacConaill, Barbara Brandner, Monica L. Calicchio, Frank C. Kuo, Azra H. Ligon, Kristen E. Stevenson, Sarah M. Kehoe, Levi A. Garraway, William C. Hahn, Matthew Meyerson, Mark D. Fleming, Barrett J. Rollins

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options

    Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options by Laurie M. Gay, Sungeun Kim, Kyle Fedorchak, Madappa N. Kundranda, Yazmín Odia, Chaitali Nangia, James Battiste, Gerardo Colón‐Otero, Steven Powell, Jeffery S. Russell, Julia A. Elvin, Jo-Anne Vergilio, James Suh, Siraj M. Ali, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies

    Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies by Jeffrey S. Ross, Laurie M. Gay, K. Wang, Jo‐Anne Vergilio, James Suh, Shakti Ramkissoon, Hilary Somerset, Jennifer M. Johnson, Jeffery S. Russell, Siraj M. Ali, Alexa B. Schrock, David Fabrizio, Garrett M. Frampton, V.A. Miller, Philip J. Stephens, Julia A. Elvin, Daniel W. Bowles

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens

    Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens by Eric A. Severson, Gregory Riedlinger, Caitlin Connelly, Jo-Anne Vergilio, Mendel Goldfinger, Shakti Ramkissoon, Garrett M. Frampton, Jeffrey S. Ross, Anthony Fratella-Calabrese, Laurie M. Gay, Siraj Ali, Vincent A. Miller, Julia A. Elvin, Mohammad Hadigol, Kim M. Hirshfield, Lorna Rodríguez-Rodríguez, Shridar Ganesan, Hossein Khiabanian

    Published 2018
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  19. 19
    Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors

    Genomic Features of Metastatic Testicular Sex Cord Stromal Tumors by Andrea Necchi, Gennady Bratslavsky, Oleg Shapiro, Julia A. Elvin, Jo‐Anne Vergilio, Jonathan Keith Killian, Nhu Ngo, Shakti Ramkissoon, Eric A. Severson, Amanda Hemmerich, Siraj M. Ali, Jon Chung, Prasanth Reddy, Vincent A. Miller, Alexa B. Schrock, Laurie M. Gay, Jeffrey S. Ross, Joseph M Jacob

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies

    Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies by Rami N. Al‐Rohil, Ashley J. Tarasen, J. Andrew Carlson, Kai Wang, Adrienne Johnson, Roman Yelensky, Doron Lipson, Julia A. Elvin, Jo‐Anne Vergilio, Siraj M. Ali, James Suh, Vincent A. Miller, Philip J. Stephens, Prasanth Ganesan, Filip Janků, Daniel D. Karp, Vivek Subbiah, Martín C. Mihm, Jeffrey S. Ross

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: